Loading

World TB Day Digital Exhibition RESULTS UK

This photo exhibition was intended to be shown at the Scottish Parliament in 2020. Due to COVID-19 restrictions, we have decided to make the exhibition available digitally to mark World TB Day on 24 March 2021.

Partners

RESULTS UK is an international development advocacy organisation working towards the eradication of poverty by 2030, aiming to help people gain access to health, education and economic opportunity.

With a network of committed volunteer advocates across the UK, it has active local groups in Edinburgh and Linlithgow.

www.results.org.uk

The Union is a global leader in the fight to end TB, which uses science to design the best treatments and policies for patients and the health workers who serve them.

www.theunion.org

Working across continents and disciplines, the Universities of Edinburgh, St. Andrews, and Queen Margaret undertake research that seeks to optimise treatment, provide improved low-cost diagnostics and imaging tools, understand the implications of zoonotic infection on health, and address the often unappreciated role of health systems in tuberculosis care.

Tuberculosis today

Despite a lack of public awareness, 1.5 million people die from tuberculosis (TB) every year, which is more than from HIV and Malaria combined.

TB is a completely curable disease. Nonetheless, a third of all people are unable to access appropriate treatment. As a result, drug resistant strains of the disease have emerged and spread. These are much more difficult to treat because of a lack of new antibiotic drugs. A third of all deaths associated with Antimicrobial Resistance (AMR) are caused by drug-resistant TB.

In Scotland, there were 271 cases of TB in 2018, which is a 7.5% decrease since 2017. The most marginalised are at greatest risk of TB, and more than one third of all cases reported were resident in the most deprived quintile. Around 60% of the people that developed TB in 2018 were born outside of Scotland, but most were diagnosed over 2 years after arrival.

Scottish universities leading the way

Scotland’s research institutions have a proud history of TB research, with Sir John Crofton having developed the first combined antibiotic regimen that still forms the basis of TB treatments today. In 2020, the Universities of Edinburgh, St Andrews and Queen Margaret continue the legacy of Sir John Crofton into the present day, working across continents and disciplines.

Their research seeks to optimise treatment, provide improved low-cost diagnostic and imaging tools, understand the implications of zoonotic infection and one health, and addresses the often unappreciated role of health systems in TB care. Their work serves patients and professionals around the world, making a tangible contribution to the delivery of the World Health Organisation’s End TB Strategy.

The following images were selected to show a range of TB challenges around the world, as well as the work of Scottish research institutions in the fight against the disease.